(Q28178809)

English

Aminopyridines for symptomatic treatment in multiple sclerosis

scientific article (publication date: 2002)

In more languages

edit

Statements

0 references

1 reference

Europe PubMed Central

title

Aminopyridines for symptomatic treatment in multiple sclerosis (English)

0 references

0 references

4

E Pucci

0 references

author name string

A Solari

series ordinal

1

0 references

B Uitdehaag

series ordinal

2

0 references

G Giuliani

series ordinal

3

0 references

C Taus

series ordinal

5

0 references

language of work or name

English

0 references

publication date

2002

0 references

2001

0 references

published in

Cochrane Database of Systematic Reviews

0 references

page(s)

CD001330

0 references

issue

4

0 references

cites work

The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001330

retrieved

21 January 2018

Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001330

retrieved

21 January 2018

Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001330

retrieved

21 January 2018

4-Aminopyridine is superior to 3,4-diaminopyridine in the treatment of patients with multiple sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001330

retrieved

21 January 2018

Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001330

retrieved

21 January 2018

The effects of 4-aminopyridine on cognitive function in patients with multiple sclerosis: a pilot study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001330

retrieved

21 January 2018

4-Aminopyridine in multiple sclerosis: prolonged administration

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001330

retrieved

21 January 2018

The fine structure of chronically active multiple sclerosis plaques

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001330

retrieved

21 January 2018

Identifiers

DOI

10.1002/14651858.CD001330

0 references

PubMed ID

12804404

0 references

11687106

0 references

(Q28178809)

Aminopyridines for symptomatic treatment in multiple sclerosis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)